PILL Holdings
Direxion Daily Pharmaceutical & Medical Bull 3X ETF
1W: -11.5%
1M: -30.6%
3M: -20.4%
YTD: +26.2%
1Y: +77.9%
3Y: +107.8%
5Y: -17.1%
$14.84
-0.12 (-0.80%)
Weekly Expected Move ±9.5%
$12
$13
$15
$16
$18
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$31M
Holdings61
Top 10 Wt16.4%
Beta1.76
% Profitable37%
Coverage73%
Portfolio Valuation
P/E35.8
P/B7.9
P/S6.1
EV/EBITDA21.3
P/FCF28.6
PEG2.52
Profitability & Returns
Gross Margin72.0%
Net Margin15.8%
ROE21.0%
ROA7.5%
ROIC16.2%
Div Yield0.66%
Leverage & Liquidity
Debt/Equity1.01
Debt/Assets0.36
Net Debt/EBITDA1.9x
Interest Cov9.7x
Current Ratio1.39
Quick Ratio1.07
Growth (YoY)
Revenue+36.9%
Net Income+38.1%
EPS+44.5%
FCF+30.9%
EBITDA+38.3%
Rev CAGR 3Y+70.9%
Quality Scores
Piotroski F5.1
Altman Z14.66
IS Quality57.6
IS Overall50.7
IS Value43.8
Median P/E-1.8
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Other | 7 | 251.5% | — |
| Healthcare | 61 | 75.8% | 4.4 |
Smart Money Overlap
2 holdings with signals
Showing 50 of 68 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | SPSIPH SWAP ASSET LEG (SPSIPHCTL) Swap | — | 96.62% | $17.9M | 2,354 | — | — | — |
| 2 | SPSIPH SWAP ASSET LEG (SPSIPHJPL) Swap | — | 61.56% | $11.4M | 1,500 | — | — | — |
| 3 | SPSIPH SWAP ASSET LEG (SPSIPHUBL) Swap | — | 48.31% | $8.9M | 1,177 | — | — | — |
| 4 | GOLDMAN FINL SQ TRSRY INST 506 Private | — | 23.40% | $4.3M | 4,325,492 | — | — | — |
| 5 | SPSIPH SWAP ASSET LEG (SPSIPHBCL) Swap | — | 17.65% | $3.3M | 430 | — | — | — |
| 6 | DREYFUS GOVT CASH MAN INS Bond | — | 4.01% | $741,078 | 741,078 | — | — | — |
| 7 | XERIS BIOPHARMA HOLDINGS INC | XERS | 1.92% | $354,140 | 35,485 | -93.5 | $1.6B | Healthcare |
| 8 | VERADERMICS INC | MANE | 1.75% | $323,416 | 2,745 | — | $4.9B | Healthcare |
| 9 | AMNEAL PHARMACEUTICALS INC | AMRX | 1.73% | $320,372 | 15,860 | 40.8 | $6.5B | Healthcare |
| 10 | VIATRIS INC | VTRS | 1.63% | $300,448 | 16,581 | -48.9 | $20.5B | Healthcare |
| 11 | LIGAND PHARMACEUTICALS | LGND | 1.59% | $294,842 | 950 | 30.3 | $6.1B | Healthcare |
| 12 | INDIVIOR PHARMACEUTICALS INC | INDV | 1.56% | $287,927 | 7,869 | 12.6 | $4.5B | Healthcare |
| 13 | ELI LILLY & CO | LLY | 1.56% | $287,865 | 243 | 38.2 | $1.1T | Healthcare |
| 14 | PERRIGO CO PLC | PRGO | 1.55% | $286,185 | 19,079 | -1.1 | $2.0B | Healthcare |
| 15 | SUPERNUS PHARMACEUTICALS INC | SUPN | 1.55% | $285,937 | 6,503 | -22.1 | $2.5B | Healthcare |
| 16 | PFIZER INC | PFE | 1.53% | $282,863 | 9,849 | 36.7 | $158.4B | Healthcare |
| 17 | ANI PHARMACEUTICALS INC | ANIP | 1.52% | $281,039 | 3,870 | 14.9 | $1.6B | Healthcare |
| 18 | LIQUIDIA CORP | LQDA | 1.51% | $279,791 | 3,958 | 18.3 | $2.5B | Healthcare |
| 19 | MERCK & CO. INC. | MRK | 1.50% | $276,765 | 1,854 | 114.5 | $356.4B | Healthcare |
| 20 | ETON PHARMACEUTICALS INC | ETON | 1.49% | $275,293 | 4,651 | 119.1 | $1.5B | Healthcare |
| 21 | Definium Therapeutics, Inc | DFTX | 1.49% | $275,188 | 7,202 | -10.9 | $5.0B | Healthcare |
| 22 | ORGANON & CO | OGN | 1.49% | $274,992 | 20,014 | 17.4 | $3.6B | Healthcare |
| 23 | JOHNSON & JOHNSON | JNJ | 1.48% | $273,992 | 1,024 | 29.6 | $617.0B | Healthcare |
| 24 | INNOVIVA INC | INVA | 1.48% | $273,332 | 12,948 | 4.2 | $1.5B | Healthcare |
| 25 | OMEROS CORP | OMER | 1.47% | $271,618 | 14,110 | 9.7 | $1.3B | Healthcare |
| 26 | CORCEPT THERAPEUTICS INC | CORT | 1.47% | $271,360 | 2,365 | 223.5 | $12.6B | Healthcare |
| 27 | MAZE THERAPEUTICS INC | MAZE | 1.45% | $267,606 | 9,904 | -9.6 | $1.5B | Healthcare |
| 28 | BRISTOL-MYERS SQUIBB CO | BMY | 1.44% | $267,029 | 4,248 | 13.5 | $124.9B | Healthcare |
| 29 | SEPTERNA INC | SEPN | 1.43% | $263,697 | 6,739 | -69.8 | $1.7B | Healthcare |
| 30 | JAZZ PHARMACEUTICALS PLC | JAZZ | 1.43% | $263,485 | 1,134 | 15.5 | $14.8B | Healthcare |
| 31 | ROYALTY PHARMA PLC- CL A | RPRX | 1.42% | $262,863 | 4,515 | 23.7 | $25.3B | Healthcare |
| 32 | ELANCO ANIMAL HEALTH INC | ELAN | 1.42% | $262,660 | 11,617 | -54.0 | $11.1B | Healthcare |
| 33 | PRESTIGE CONSUMER HEALTHCARE | PBH | 1.42% | $262,585 | 5,618 | 12.6 | $2.1B | Healthcare |
| 34 | ZOETIS INC | ZTS | 1.42% | $262,360 | 3,732 | 11.5 | $29.2B | Healthcare |
| 35 | HARMONY BIOSCIENCES HOLDINGS | HRMY | 1.40% | $258,292 | 6,574 | 12.7 | $2.3B | Healthcare |
| 36 | COLLEGIUM PHARMACEUTICAL INC | COLL | 1.38% | $254,267 | 11,438 | 14.4 | $714M | Healthcare |
| 37 | TARSUS PHARMACEUTICALS INC | TARS | 1.37% | $253,460 | 3,305 | -67.0 | $3.1B | Healthcare |
| 38 | MBX BIOSCIENCES INC | MBX | 1.36% | $251,155 | 4,349 | -24.4 | $2.8B | Healthcare |
| 39 | AMYLYX PHARMACEUTICALS INC | AMLX | 1.34% | $247,240 | 8,444 | -19.7 | $3.1B | Healthcare |
| 40 | EDGEWISE THERAPEUTICS INC | EWTX | 1.34% | $247,093 | 6,305 | -22.4 | $4.5B | Healthcare |
| 41 | PACIRA BIOSCIENCES INC | PCRX | 1.32% | $244,573 | 9,535 | 71.6 | $992M | Healthcare |
| 42 | AXSOME THERAPEUTICS INC | AXSM | 1.31% | $241,796 | 1,299 | -47.8 | $9.2B | Healthcare |
| 43 | TREVI THERAPEUTICS INC | TRVI | 1.28% | $237,094 | 16,442 | -41.2 | $2.0B | Healthcare |
| 44 | NUVATION BIO INC | NUVB | 1.28% | $235,826 | 41,962 | -11.8 | $1.8B | Healthcare |
| 45 | HARROW INC | HROW | 1.24% | $228,780 | 7,286 | -30.7 | $1.1B | Healthcare |
| 46 | ENLIVEN THERAPEUTICS INC | ELVN | 1.20% | $221,481 | 4,762 | -28.6 | $3.4B | Healthcare |
| 47 | AMPHASTAR PHARMACEUTICALS IN | AMPH | 1.19% | $219,897 | 8,242 | 14.6 | $1.1B | Healthcare |
| 48 | ZEVRA THERAPEUTICS INC | ZVRA | 1.18% | $218,987 | 19,311 | 10.4 | $591M | Healthcare |
| 49 | ALUMIS INC | ALMS | 1.10% | $203,522 | 27,918 | -1.8 | $846M | Healthcare |
| 50 | RAPPORT THERAPEUTICS INC | RAPP | 1.03% | $191,252 | 5,792 | -10.6 | $1.5B | Healthcare |